CEL-SCI Reports Recent Data Review By Independent Data Monitoring Committee For Phase 3 Head and Neck Cancer Study; Independent Data Monitoring Committee Recommends Continuation Of Trial Until Appropriate Number Of Events Have Occurred
Benzinga Newsdesk